Literature DB >> 22987949

New insights into pancreatic cancer biology.

M Hidalgo1.   

Abstract

Pancreatic cancer remains a devastating disease. Over the last few years, there have been important advances in the molecular and biological understanding of pancreatic cancer. This included understanding of the genomic complexity of the disease, the role of pancreatic cancer stem cells, the relevance of the tumor microenvironment, and the unique metabolic adaptation of pancreas cancer cells to obtain nutrients under hypoxic environment. In this paper, we review the most salient developments in these few areas.

Entities:  

Mesh:

Year:  2012        PMID: 22987949     DOI: 10.1093/annonc/mds313

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  33 in total

Review 1.  Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Authors:  Irene Esposito; Björn Konukiewitz; Anna Melissa Schlitter; Günter Klöppel
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 2.  Pancreatic biomarkers: could they be the answer?

Authors:  Angela Lamarca; Jaime Feliu
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

3.  Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.

Authors:  Julie Leca; Sébastien Martinez; Sophie Lac; Jérémy Nigri; Véronique Secq; Marion Rubis; Christian Bressy; Arnauld Sergé; Marie-Noelle Lavaut; Nelson Dusetti; Céline Loncle; Julie Roques; Daniel Pietrasz; Corinne Bousquet; Stéphane Garcia; Samuel Granjeaud; Mehdi Ouaissi; Jean Baptiste Bachet; Christine Brun; Juan L Iovanna; Pascale Zimmermann; Sophie Vasseur; Richard Tomasini
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

4.  Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State.

Authors:  Anna M Nguyen; Jianhong Zhou; Brihget Sicairos; Sangeetha Sonney; Yuchun Du
Journal:  Mol Cell Proteomics       Date:  2019-12-26       Impact factor: 5.911

Review 5.  Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer.

Authors:  Flavio G Rocha
Journal:  Ann Surg Oncol       Date:  2021-01-01       Impact factor: 5.344

6.  Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.

Authors:  Daniela Laura Papademetrio; Silvina Laura Lompardía; Tania Simunovich; Susana Costantino; Cintia Yamila Mihalez; Victoria Cavaliere; Élida Álvarez
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

7.  Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival.

Authors:  Mary C Patton; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; Ajay P Singh
Journal:  J Cell Biochem       Date:  2019-08-12       Impact factor: 4.429

8.  Inhibition of pancreatic tumoral cells by snake venom disintegrins.

Authors:  Sara Lucena; Roberto Castro; Courtney Lundin; Amanda Hofstetter; Amber Alaniz; Montamas Suntravat; Elda Eliza Sánchez
Journal:  Toxicon       Date:  2014-11-20       Impact factor: 3.033

9.  Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Authors:  Vasilios Karavasilis; Epaminontas Samantas; Georgia-Angeliki Koliou; Anna Kalogera-Fountzila; George Pentheroudakis; Ioannis Varthalitis; Helena Linardou; Grigorios Rallis; Maria Skondra; Georgios Papadopoulos; George Papatsibas; Joseph Sgouros; Athina Goudopoulou; Konstantine T Kalogeras; Christos Dervenis; Dimitrios Pectasides; George Fountzilas
Journal:  Target Oncol       Date:  2018-12       Impact factor: 4.493

Review 10.  Intervention on toll-like receptors in pancreatic cancer.

Authors:  Juan Vaz; Roland Andersson
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.